Abstract

Nanoparticles from chitosan, in general, can be prepared through ionotropic gelation, physical crosslinking, with anionic polyphosphates. Tripolyphosphate (TPP) is widely used for such purpose especially in drug delivery applications. TPP is a small ion with a triple negative charge throughout the physiologically acceptable pH range. However, the stability of size and surface charge of the particles still challenging. In the current work, the utilization of Hexametaphosphate (HMP) instead of Tripolyphosphate (TPP) as a cross-linking agent is being investigated. HMP is hexavalent molecule in the neutral and slightly basic medium which offers more binding sites readily available for interaction with chitosan. It is thought that increasing the availability of the binding sites in the HMP molecule would result in stronger ionic complexation with chitosan cationic charges. Consequently, such stronger binding improves particles' stability and lead to average size reduction. A comparative study between chitosan/TPP and chitosan/HMP nanoparticles under different complexation conditions was conducted to investigate the effect of HMP on nanoparticles formation. Bovine Serum Albumin (BSA) was applied as a protein model drug to explore the drug loading efficiency, 96.3%, is higher than its TPP, 91.87%, counterparts. However, TPP cross-linked particles showed superior stability upon storage.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.